Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 diabetes may face an overlooked risk: nutritional deficiencies. A new study found that nearly 1 in 6 young patients developed a diagnosed deficiency within a year of starting treatment, with vitamin D deficiency affecting about 12%.
Source: https://www.sciencedaily.com/releases/2 ... 035926.htm
Source: https://www.sciencedaily.com/releases/2 ... 035926.htm
